Skip to content

New HIV clinical training resource available from Impact/Family Health International

AIDSpan Guide to applying to the Global Fund

Resistant HIV strains persist after at least five years on suppressive HAART

Fosamprenavir recommended for approval as Telzir in Europe

US treatment guidelines updated

Atazanavir interactions with tenofovir and Viagra included on new US labelling

Need for new TB test highlighted on World TB Day

Kidney stones and other calculus build-up seen in 4% of those on Kaletra-based HAART

HAART takes more than a year to suppress Kaposi’s sarcoma virus